8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2015 / Randomized controlled trial
Postmenopausal osteopenic women were randomized to receive 1 g/d of creatine (n = 56) or dextrose placebo (n = 53) for one year. Bone mineral density at the spine, hip sites, and total skeleton showed no significant differences between or within treatment arms. Similarly, creatine did not significantly change body composition, lean mass, timed-up-and-go performance, or timed-stands test scores.
Lobo DM, Tritto AC, da Silva LR, et al. Exp Gerontol, 2015. PMID 26192975
2015 / Randomized controlled trial
In an ancillary trial within AREDS2, 3,501 older adults at risk for late age-related macular degeneration were randomized to receive omega-3 polyunsaturated fatty acids, lutein/zeaxanthin, both, or placebo. Over five years, yearly change in composite cognitive test scores did not differ between the fatty acid group (-0.19; 99% CI, -0.25 to -0.13) and control (-0.18; 99% CI, -0.24 to -0.12; P = .63). Similarly, lutein/zeaxanthin showed no difference compared to placebo (P = .66).
Chew EY, Clemons TE, Agrón E, et al. JAMA, 2015. PMID 26305649
2015 / Randomized controlled trial
Twenty-four elderly patients diagnosed with depression were randomly divided into an experimental group practicing Nordic walking and a control group practicing normal walking. Both groups exercised for 50 minutes per day, three times per week for eight weeks. Both groups showed significant improvements in depression over time, with significant differences over time between groups for depression, sleep, and skeletal muscle mass.
Park SD, Yu SH J Phys Ther Sci, 2015. PMID 26357429
2015 / Randomized, double-blind, placebo-controlled phase 2 trial
In a 52-week phase 2 trial, 119 participants with mild to moderate Alzheimer disease were randomized to placebo or oral resveratrol (dose-escalated from 500 mg daily to 1,000 mg twice daily). Resveratrol and its major metabolites penetrated the blood-brain barrier. The most frequent adverse events were nausea, diarrhea, and weight loss. CSF Aβ40 and plasma Aβ40 levels declined more in the placebo group than in the resveratrol group, producing a significant difference at week 52, while brain volume loss was increased with resveratrol compared to placebo.
Turner RS, Thomas RG, Craft S, et al. Neurology, 2015. PMID 26362286
2015 / Randomized, double-blind, placebo-controlled trial
In a 2-year trial, older women aged 70-80 years were assigned to a daily drink containing either 30 g whey protein (n = 109) or 2.1 g protein placebo (n = 110). A mean increase of ~20 g/d protein was confirmed in the protein group via 24-hour urinary nitrogen. Over 2 years, both groups experienced significant declines in upper arm muscle area (-5.59 ± 0.75 cm²), calf muscle area (-0.77 ± 0.11 cm²), and hand grip strength (-1.30 ± 0.3 kg) (all P < 0.05). However, there were no significant effects of protein supplementation on any muscle mass or physical function measures at 1 and 2 years (all P > 0.05).
Zhu K, Kerr DA, Meng X, et al. J Nutr, 2015. PMID 26400966
2015 / Twin study and controlled animal intervention
Researchers evaluated genetic factors, physical activity, cardiorespiratory fitness, and mortality using human twins and laboratory rats. In both animals and/or human twins, the same genetic factors influenced physical activity levels, cardiorespiratory fitness, and risk of death. Findings from a controlled interventional study with rats bred for low and high intrinsic fitness contrasted with previous human observational studies suggesting that increasing fitness through activity could prolong life. Additionally, pairwise analysis among monozygotic twin pairs discordant in physical activity levels found no evidence for the suggested association, leading authors to propose genetic pleiotropy as a partial explanation.
Karvinen S, Waller K, Silvennoinen M, et al. Sci Rep, 2015. PMID 26666586
2014 / Randomized controlled trial
Healthy adults aged >=50 years were randomly assigned to exercise (n=47), MBSR (n=51), or a waitlist control condition (n=51) and received trivalent inactivated influenza vaccine after 6 weeks. No differences in vaccine responses were found between the control group and the MBSR or exercise groups. However, individuals achieving seroprotective antibody levels (>=160 units) had higher optimism, less anxiety, and lower perceived stress, while age correlated with antibody responses.
Hayney MS, Coe CL, Muller D, et al. Hum Vaccin Immunother, 2014. PMID 24096366
2014 / Randomized controlled trial
A clinical trial randomized 105 cognitively intact adults aged 65 to 85 years to receive either the NT-020 nutraceutical (n=52) or placebo (n=53) for two months. Participants receiving the supplement showed significant improvements on two tests of processing speed compared to the placebo group. Scores across five other evaluated cognitive areas did not differ between treatment groups, and adverse event rates were similar.
Small BJ, Rawson KS, Martin C, et al. Rejuvenation Res, 2014. PMID 24134194
2014 / Randomized controlled trial
In a randomized multicenter trial, 4,203 participants aged 50 to 85 years at risk of late age-related macular degeneration (AMD) evaluated lutein/zeaxanthin (10 mg/2 mg) versus no lutein/zeaxanthin or beta carotene. Lutein/zeaxanthin reduced the risk of progression to late AMD compared to no lutein/zeaxanthin (HR 0.90, 95% CI 0.82-0.99; P = 0.04). Compared directly with beta carotene, lutein/zeaxanthin showed a reduced risk of late AMD (HR 0.82, 95% CI 0.69-0.96; P = 0.02).
Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, et al. JAMA Ophthalmol, 2014. PMID 24310343
2014 / Double-blind, placebo-controlled randomized clinical trial
A randomized trial investigated the effects of 2000 IU/d of alpha tocopherol, 20 mg/d of memantine, their combination, or placebo in 613 patients with mild to moderate Alzheimer disease over a mean follow-up of 2.27 years. Over follow-up, ADCS-ADL scores declined by 3.15 units less in the alpha tocopherol group compared with placebo (95% CI, 0.92 to 5.39; adjusted P = .03), corresponding to an annualized 19% delay in clinical progression. Decline in the memantine group was not significantly different from placebo (1.98 units less; 95% CI, -0.24 to 4.20; adjusted P = .40), nor were significant differences seen for combination therapy. Caregiver time increased least with alpha tocopherol, while serious adverse events for infections or infestations were higher in the memantine and combination groups compared with placebo.
Dysken MW, Sano M, Asthana S, et al. JAMA, 2014. PMID 24381967
2014 / Parallel comparator trial
In a parallel comparator trial, 10 younger (19-28 years) and 10 older (45-64 years) healthy individuals consumed one muffin per day containing 30 g of milled flaxseed (6 g alpha-linolenic acid) for 4 weeks. At baseline, the older group showed 13 oxylipins at least 2-fold higher than the younger group, including significantly higher 5-HETE (1.1±0.23 nM vs 0.34±0.12 nM), 9,10,13-TriHOME (5.6±0.84 nM vs 3.5±0.33 nM), and 9,12,13-TriHOME (4.5±0.58 nM vs 3.0±0.24 nM) (p<0.05). After 4 weeks of flaxseed intake, the number of oxylipins ≥2-fold higher in the older group fell to 3, and 5-HETE, 9,10,13-TriHOME, and 9,12,13-TriHOME decreased in the older group to concentrations equivalent to the younger group.
Caligiuri SP, Aukema HM, Ravandi A, et al. Exp Gerontol, 2014. PMID 24747581
2014 / Pilot randomized controlled trial
In a pilot randomized trial, 19 ambulatory women aged 40 years and older with urinary incontinence were randomized to a 6-week yoga therapy program (twice weekly group classes and once weekly home practice; n = 10) or a wait-list control group (n = 9). After 6 weeks, total incontinence frequency decreased by 70% (1.8 [0.9] fewer episodes/d) in the yoga group versus 13% (0.3 [1.7] fewer episodes/d) in controls (P = 0.049). Stress incontinence frequency decreased by 71% (0.7 [0.8] fewer episodes/d) with yoga compared with a 25% increase in controls (0.2 [1.1] more episodes/d; P = 0.039), while urgency incontinence did not significantly differ (P = 0.20). All yoga participants completed at least 90% of sessions, and two participants in each group reported unrelated adverse events.
Huang AJ, Jenny HE, Chesney MA, et al. Female Pelvic Med Reconstr Surg, 2014. PMID 24763156
2014 / Randomized controlled trial
Osteopenic postmenopausal women (n=160) were randomized to consume either 100 g dried plum/d or 75 g dried apple/d for 1 year, with all participants receiving daily calcium (500 mg) and vitamin D (400 IU). Dried plum significantly increased the BMD of the ulna and spine compared with the dried apple control group. Compared to baseline, dried plum changed RANKL (+1.99% vs. +18.33%), OPG (+4.87% vs. -2.15%), and sclerostin (-1.12% vs. +3.78%) relative to control, though these biomarker percentage changes did not reach statistical significance (P <= 0.05).
Hooshmand S, Brisco JR, Arjmandi BH Br J Nutr, 2014. PMID 24780728
2014 / Randomized controlled trial (secondary analysis)
A total of 107 frail, obese older adults were randomized to a control, diet, exercise, or diet-plus-exercise group for 1 year. 3MS cognition scores improved more in the diet (mean ± SE: 1.7 ± 0.4), exercise (2.8 ± 0.4), and diet-exercise (2.9 ± 0.4) groups than in the control group (0.1 ± 0.4; between-group P = 0.0001-0.04), with diet-exercise improving more than diet but not exercise alone. IWQOL scores also improved more in the diet (7.6 ± 1.6), exercise (10.1 ± 1.6), and diet-exercise (14.0 ± 1.4) groups than control (0.3 ± 1.6; P = 0.0001-0.03), again with diet-exercise showing greater improvement than diet alone but not exercise alone. Word Fluency and Trail Making Test scores also improved with exercise-containing interventions, while Geriatric Depression Scale scores did not change.
Napoli N, Shah K, Waters DL, et al. Am J Clin Nutr, 2014. PMID 24787497
2014 / Multicenter randomized controlled trial
In the LIFE multicenter randomized trial, 1,635 sedentary older adults with physical limitations were assigned to a structured, moderate-intensity physical activity program (n=818) or a health education program (n=817) for an average of 2.6 years. Incident major mobility disability occurred in 30.1% (246 participants) of the physical activity group vs. 35.5% (290 participants) of the health education group (HR 0.82 [95% CI, 0.69-0.98], P=.03). Persistent mobility disability was also lower in the physical activity group (14.7% vs. 19.8%; HR 0.72 [95% CI, 0.57-0.91]; P=.006). Serious adverse events occurred in 49.4% of the physical activity group and 45.7% of the health education group (risk ratio, 1.08 [95% CI, 0.98-1.20]).
Pahor M, Guralnik JM, Ambrosius WT, et al. JAMA, 2014. PMID 24866862
2014 / Preclinical animal model with preliminary human clinical data
Researchers investigated the effects of prolonged fasting on hematopoietic stem cell protection and regeneration in mice, supplemented by preliminary data from fasting patients. Prolonged fasting lowered circulating IGF-1 levels and PKA activity, promoting stress resistance, self-renewal, and lineage-balanced regeneration in long-term hematopoietic stem cells. Multiple fasting cycles abated chemotherapy-induced immunosuppression and mortality and reversed age-dependent myeloid bias in mice, aligning with preliminary findings indicating lymphocyte protection against chemotoxicity in fasting patients. The proregenerative effects were reproduced by IGF-1 or PKA deficiencies and blunted by exogenous IGF-1.
Cheng CW, Adams GB, Perin L, et al. Cell Stem Cell, 2014. PMID 24905167
2014 / 12-week exercise training intervention study
Researchers evaluated whether changes in body size were independently related to changes in central blood pressure in 11 men and 84 women from a rural village undergoing a 12-week training program. Following the program, weight loss correlated strongly with reductions in brachial mean arterial pressure (MAP), radial SBP1, SBP2, and heart-rate-corrected augmentation index (AI@75). After adjusting for confounding factors, weight loss was significantly and independently associated with reductions in brachial MAP (β=0.34, P=0.001), radial SBP1 (β=0.31, P=0.002), SBP2 (β=0.37, P<0.001), and AI@75 (β=0.36, P=0.001).
Kawamoto R, Kohara K, Katoh T, et al. Hypertens Res, 2014. PMID 24965169
2014 / Parallel-group, randomized controlled trial
In a randomized controlled trial, 139 healthy elderly women were assigned to 300 mg/d oral magnesium (n=62) or a control group with no intervention (n=77) for 12 weeks alongside a weekly fitness program; 124 participants completed the final analysis. After 12 weeks, the magnesium group showed significantly better total SPPB scores (Δ = 0.41 ± 0.24 points; P = 0.03), chair stand times (Δ = -1.31 ± 0.33 s; P < 0.0001), and 4-m walking speeds (Δ = 0.14 ± 0.03 m/s; P = 0.006) compared to controls. These effects were more pronounced in participants with baseline dietary magnesium intake below the Recommended Dietary Allowance. No significant differences were observed for lower limb or handgrip strength, and no serious adverse events occurred.
Veronese N, Berton L, Carraro S, et al. Am J Clin Nutr, 2014. PMID 25008857
2014 / Double-blind randomized controlled trial
In a double-blind metabolic study, 48 people aged 60 years or older with untreated pre-diabetes received placebo, turmeric (1 g), cinnamon (2 g), or both alongside a white bread breakfast, with outcomes tracked over 6 hours. Working memory increased from 2.6 to 2.9 out of 3.0 (p=0.05) with turmeric, while cinnamon showed no change and no interaction between the two was detected. Working memory improvement was inversely associated with insulin resistance (r=-0.418, p<0.01), but not with Alzheimer's disease biomarkers. In multivariable linear regression, working memory responses to turmeric were best predicted with an R2 of 34.5%, with significant beta-coefficients for turmeric, BMI, and insulin/glucose AUC.
Lee MS, Wahlqvist ML, Chou YC, et al. Asia Pac J Clin Nutr, 2014. PMID 25516316
2014 / Controlled trial
Thirty-six elderly women were divided into a yoga group and a control group to evaluate the effects of a 12-week yoga program (65-minute sessions, 3 times/week) on pulmonary volumes and respiratory muscle strength. In the yoga group, heart rate decreased from 76-39 ± 8-03 to 74-61 ± 10.26 bpm and respiratory rate decreased from 18.61 ± 3.15 to 16.72 ± 3.12 resp/min. Tidal volume and minute ventilation increased from 0.55 ± 0.22 to 0.64 ± 0.2 ml and 9.19 ± 2.39 to 10.05 ± 2.11 ml, respectively, while vital capacity increased from 1.48 ± 0.45 to 2.03 ± 0.72 ml. Maximal inspiratory pressure improved from 62.17 ± 14.77 to 73.06 ± 20.16 cmH2O and maximal expiratory pressure improved from 80.56 ± 23.94 to 86.39 ± 20.16 cmH2O.
Bezerra LA, de Melo HF, Garay AP, et al. J Hum Kinet, 2014. PMID 25713658
2014 / Controlled intervention trial
Ninety postmenopausal women aged 45-60 years were divided into three groups of 30. Group II received 7 g drumstick leaves powder (DLP) daily, Group III received 9 g amaranth leaves powder (ALP) daily, and Group I received no supplement for 3 months. Compared to baseline, DLP and ALP significantly increased serum retinol (8.8% and 5.0%), ascorbic acid (44.4% and 5.9%), glutathione peroxidase (18.0% and 11.9%), and superoxide dismutase (10.4% and 10.8%), while decreasing malondialdehyde (16.3% and 9.6%). Fasting blood glucose decreased significantly (13.5% and 10.4%) and hemoglobin increased (17.5% and 5.3%) in groups II and III, respectively.
Kushwaha S, Chawla P, Kochhar A J Food Sci Technol, 2014. PMID 26396347
2013 / Randomized controlled trial
Thirty-nine dementia caregivers with depressive symptoms were randomized to 12 minutes daily of Kirtan Kriya meditation or relaxation music for 8 weeks. The meditation group had significantly fewer depressive symptoms and greater mental and cognitive gains, with 65.2% achieving 50% improvement on the Hamilton Depression Rating scale versus 31.2% in controls. Peripheral blood mononuclear cell telomerase activity improved by 43% with meditation compared to 3.7% with relaxation music.
Lavretsky H, Epel ES, Siddarth P, et al. Int J Geriatr Psychiatry, 2013. PMID 22407663
2013 / Double-blind randomized controlled trial
In a 4-month double-blind trial, 106 healthy sedentary overweight middle-aged and older adults were randomized to receive 2.5 g/day n-3 PUFAs, 1.25 g/day n-3 PUFAs, or placebo. Supplementation significantly lowered oxidative stress as measured by F2-isoprostanes (p=0.02), with estimated geometric mean log values being 15% lower in the supplemented groups versus placebo. While direct group differences for telomerase and telomere length were nonsignificant, leukocyte telomere length increased with decreasing n-6:n-3 plasma ratios (p=0.02).
Kiecolt-Glaser JK, Epel ES, Belury MA, et al. Brain Behav Immun, 2013. PMID 23010452
2013 / Randomized, double-blind, placebo-controlled trial
In a randomized, double-blind, placebo-controlled trial, 201 healthy older adults without osteoporosis were assigned to 60 mEq of oral potassium citrate daily or placebo for 24 months alongside calcium and vitamin D. Potassium citrate increased lumbar spine areal BMD from baseline by 1.7 ± 1.5% net of placebo (95% CI 1.0-2.3, P < 0.001). Trabecular densities also increased at the nondominant tibia (1.3 ± 1.3%, P < 0.001) and nondominant radius (2.0 ± 2.0%, P < 0.001), alongside improvements in trabecular bone volume/tissue volume (0.9 ± 0.8%), thickness (1.5 ± 1.6%), and number (1.9 ± 1.8%, all P < 0.05). Potassium citrate also significantly decreased FRAX fracture prediction scores in both sexes.
Jehle S, Hulter HN, Krapf R J Clin Endocrinol Metab, 2013. PMID 23162100